Prostate cancer (PCa) is a common malignancy in males. The pathology review of PCa is
crucial for clinical decision-making, but traditional pathology review is labor intensive and …

The ETS-related gene (ERG) is proto-oncogene that is classified as a member of the ETS
transcription factor family, which has been found to be consistently overexpressed in about …

Background & Aims RNA N 6-methyladenosine (m 6 A) reader protein YTHDF1 has been
implicated in cancer; however, its role in hepatocellular carcinoma (HCC), especially in non …

In the era of precision medicine, it has been increasingly recognized that individuals with a
certain disease are complex and different from each other. Due to the underestimation of the …

Prostate cancer, as one of the most prevalent malignancies in males, exhibits an
approximate 5-year survival rate of 95% in advanced stages. A myriad of molecular events …

Glioblastoma (GBM) is the most lethal primary brain tumor in adults and harbors a
subpopulation of glioma stem cells (GSCs). Enhancer of Zeste Homolog 2 (EZH2), a histone …

Simple Summary In addition to its role in development and in the vascular and
hematopoietic systems, ERG plays a central role in prostate cancer. Approximately 40–50 …

Castration-resistant prostate cancer (CRPC) is a frequently occurring disease with adverse
clinical outcomes and limited therapeutic options. Here, we identify methionine …

Since the theory of modern anatomical partitioning of the prostate was proposed, the
differences in the incidence and pathological parameters of prostate cancer between the …

Simple Summary Oncofusions, or cancer-associated fusion mutations, are driving forces in
cancer development. Advanced sequencing technologies have revolutionized their …